Cost-effectiveness considerations for managed care systems: Treating depression in primary care

Bentson H. McFarland

Research output: Contribution to journalArticlepeer-review

52 Scopus citations


This article addresses the management of depression in primary care from the perspective of a health maintenance organization. The rise of managed care systems is briefly discussed with reference to their impact on choice of treatment strategies. Cost-effectiveness considerations pertinent to a health maintenance organization are reviewed. A simplified protocol for the treatment of depression with paroxetine or imipramine in the primary care sector is presented and used as an example of cost calculations. Given the assumptions used in this cost-effectiveness model, it appears that the costs of treating depression in primary care with paroxetine are approximately equal to those found with the use of imipramine. Higher acquisition costs of paroxetine are balanced by the greater labor costs associated with imipramine.

Original languageEnglish (US)
Pages (from-to)S47-S58
JournalThe American Journal of Medicine
Issue number6 SUPPL. 1
StatePublished - Dec 19 1994

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Cost-effectiveness considerations for managed care systems: Treating depression in primary care'. Together they form a unique fingerprint.

Cite this